Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT01045187 · ClinicalTrials.gov registry record · NA

Feasibility Study Using the Xoft System for the Treatment of Endometrial Cancer

A NA study, sponsored by Xoft.

Completed
Registry status
NA
Development phase
15
Enrollment target

NCT01045187: Completed NA study, sponsored by Xoft.

NCT01045187 is a NA study that has completed, run by Xoft. The registered enrollment target is 15 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (99% lower). According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT01045187, a NA study, has completed, sponsored by Xoft.

COMPLETED
Registry status
NA
Development phase
15 participants
Enrollment target

Study Summary

Multicenter, non-randomized, feasibility study to evaluate the treatment and assess acute safety of the FDA Cleared Axxent Electronic Brachytherapy System and vaginal applicator for intracavitary vaginal cuff treatment according to the physician's current standard of care.

Interventions

  • RADIATION brachytherapy
  • RADIATION Xoft Axxent Electronic Brachytherapy System

Trial Details

FieldValue
Enrollment Target 15 participants
Start Date 2008-10
Est. Completion 2010-04
Phase NA
Xoft

10 total trials

What the finished NCT01045187 record still lists

NCT01045187 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 15 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (99% lower).

The record links to 0 conditions, and to 2 interventions - of which brachytherapy is the first listed.

NCT01045187 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT01045187 about?

NCT01045187 is a clinical study titled "Feasibility Study Using the Xoft System for the Treatment of Endometrial Cancer". Multicenter, non-randomized, feasibility study to evaluate the treatment and assess acute safety of the FDA Cleared Axxent Electronic Brachytherapy System and vaginal applicator for intracavitary vaginal cuff treatment according to the physician's current standard of care.

What is the current status of trial NCT01045187?

This trial is currently completed. It is a NA study. The enrollment target is 15 participants. The study started on 2008-10. Estimated completion is 2010-04.

What interventions are being tested in trial NCT01045187?

The interventions under investigation include: brachytherapy (RADIATION), Xoft Axxent Electronic Brachytherapy System (RADIATION).

Who is sponsoring clinical trial NCT01045187?

This trial is sponsored by Xoft, which has 10 total clinical trials registered on ClinicalTrials.gov.

How this trial's enrollment target compares

Where NCT01045187's enrollment target sits among peer trials

15 1881st of 2000 higher than 92 of 2,000 other NA trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT01889381 · 15 participants · Phase 2

    Human Craniomaxillofacial Allotransplantation

  • NCT02530073 · 15 participants · NA

    Trial of Fetoscopic Endoluminal Tracheal Occlusion (FETO) for CDH

  • NCT02535936 · 15 participants · NA

    Cortical Plasticity in Spastic Diplegia After Selective Dorsal Rhizotomy

  • NCT02918474 · 15 participants · NA

    Decision Making Tool in Supporting Decision Making in Contralateral Prophylactic Mastectomy in Patients With Newly Diagnosed Breast Cancer

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT01045187, the US trial registry maintained by the National Library of Medicine. NCT01045187 (small enrollment · none site footprint · completed) retrieved and formatted by PlainTrial, see methodology.